152 related articles for article (PubMed ID: 29327476)
1. O-GlcNAcylation in oral squamous cell carcinoma.
Kongkaew T; Aung WPP; Supanchart C; Makeudom A; Langsa-Ard S; Sastraruji T; Chaiyarit P; Krisanaprakornkit S
J Oral Pathol Med; 2018 Mar; 47(3):260-267. PubMed ID: 29327476
[TBL] [Abstract][Full Text] [Related]
2. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation of the human epidermal growth factor receptor.
Stateva SR; Villalobo A
Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
[TBL] [Abstract][Full Text] [Related]
4. Lewisy promotes migration of oral cancer cells by glycosylation of epidermal growth factor receptor.
Lin WL; Lin YS; Shi GY; Chang CF; Wu HL
PLoS One; 2015; 10(3):e0120162. PubMed ID: 25799278
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the correlation of the expression level of hypoxia-inducible factor-1α with the glycosylation of oral squamous cell carcinoma.
Xu X; Liu H; Wu R; Zuo W; Wang T; Chen D
Am J Transl Res; 2021; 13(6):6686-6693. PubMed ID: 34306413
[TBL] [Abstract][Full Text] [Related]
6. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A; Krisanaprakornkit S
Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
[TBL] [Abstract][Full Text] [Related]
9. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
11. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
12. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells.
Ramirez DH; Aonbangkhen C; Wu HY; Naftaly JA; Tang S; O'Meara TR; Woo CM
ACS Chem Biol; 2020 Apr; 15(4):1059-1066. PubMed ID: 32119511
[TBL] [Abstract][Full Text] [Related]
13. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
Zanotti L; Paderno A; Piazza C; Pagan E; Bignotti E; Romani C; Bandiera E; Calza S; Del Bon F; Nicolai P; Ravaggi A
Laryngoscope; 2017 Nov; 127(11):E408-E414. PubMed ID: 28782189
[TBL] [Abstract][Full Text] [Related]
16. Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC).
Richter P; Böhmer FD; Hindermann W; Borsi L; Hyckel P; Schleier P; Katenkamp D; Kosmehl H; Berndt A
Histochem Cell Biol; 2005 Aug; 124(2):151-60. PubMed ID: 16052324
[TBL] [Abstract][Full Text] [Related]
17. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells.
Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M
Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285
[TBL] [Abstract][Full Text] [Related]
19. Placental O-GlcNAc-transferase expression and interactions with the glucocorticoid receptor are sex specific and regulated by maternal corticosterone exposure in mice.
Pantaleon M; Steane SE; McMahon K; Cuffe JSM; Moritz KM
Sci Rep; 2017 May; 7(1):2017. PubMed ID: 28515473
[TBL] [Abstract][Full Text] [Related]
20. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]